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Abstract
We previously demonstrated that the opioid peptide, enkephalin, and corticotropinreleasing factor (CRF) are occasionally co-localized in individual axon terminals but
more frequently converge on common dendrites in the locus coeruleus (LC). To further
examine potential opioid co-transmitters in CRF afferents, we investigated the
distribution of proopiomelanocortin (POMC), the precursor that yields the potent
bioactive peptide, -endorphin, with respect to CRF immunoreactivity using
immunofluorescence and immunoelectron microscopic analyses of the LC. Coronal
sections were collected through the dorsal pontine tegmentum of rat brain and processed
for immunocytochemical detection of POMC and CRF or tyrosine hydroxylase (TH).
POMC-immunoreactive processes exhibited a distinct distribution within the LC as
compared to the enkephalin family of opioid peptides. Specifically, POMC fibers were
enriched in the ventromedial aspect of the LC with fewer fibers present dorsolaterally.
Immunofluorescence microscopy showed frequent co-existence of POMC and CRF in
varicose processes that overlapped TH-containing somatodendritic processes in the LC.
Ultrastructural analysis showed POMC immunoreactivity in unmyelinated axons and
axon terminals. Axon terminals containing POMC were filled with numerous large dense
core vesicles. In sections processed for POMC and TH, approximately 29% of POMCcontaining axon terminals (n = 405) targeted dendrites that exhibited immunogold-silver
labeling for TH. Whereas, sections processed for POMC and CRF showed that 27% of
POMC-labeled axon terminals (n = 657) also exhibited CRF immunoreactivity. Taken
together, these data indicate that a subset of CRF afferents targeting the LC contain
POMC and may be positioned to dually impact LC activity.
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Introduction
We have previously demonstrated that corticotropin-releasing factor (CRF) and
endogenous opioids interact in the locus coeruleus (LC) to modulate noradrenergic
function (Valentino et al., 1992; Van Bockstaele et al., 1996a; Van Bockstaele et al.,
1996b; Xu et al., 2004). Specifically, we showed that chronic morphine administration
sensitized the LC neurons to CRF (Xu et al., 2004). In an effort to further elucidate
interactions between CRF and opioid associated with peptides that modulate mu-opioid
receptors, we examined here the distribution of proopiomelanocortin (POMC), an opioid
precursor, and CRF in this noradrenergic nucleus.
POMC is processed to yield the potent bioactive peptide, F-endorphin, which is
associated with stress regulation (Baubet et al., 1994). -endorphin interacts with µopioid receptors to mediate stress-induced analgesia (Rubinstein et al., 1996) and it has
been implicated in nociception (Foley et al., 1979; Yaksh et al., 1982; Bertolini et al.,
1986; Baubet et al., 1994). In the present study, the ultrastructural distribution of POMC
and catecholamine-containing neurons in the LC that may likely underlie the effects of
POMC were investigated using immunofluorescence and electron microscopy in the rat
brain.
Previous studies suggest that the LC is densely innervated by processes exhibiting
endogenous opioid peptides including leucine- and methionine-enkephalin (Drolet et al.,
1992; Van Bockstaele et al., 1995; Van Bockstaele et al., 1996c; Van Bockstaele &
Chan, 1997; Van Bockstaele et al., 2000), F-endorphin (Bloom et al., 1978a; Bloom et
al., 1978b), and dynorphin (Fallon & Leslie, 1986). Likewise, LC neurons demonstrate a
high concentration of opioid receptors including µ-opioid receptors (Tempel & Zukin,
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1987; Mansour et al., 1994; Mansour et al., 1995; Van Bockstaele et al., 1996a; Van
Bockstaele et al., 1996b).
Known for its population of noradrenergic neurons, the LC projects throughout all
levels of the neuroaxis (Foote et al., 1983). Thus, LC neurons serve as the prime source
of NE in the forebrain (Aston-Jones et al., 1985; McCormick et al., 1991).
Electrophysiological and pharmacological studies showed a critical role of noradrenergic
projections from the LC in the control of vigilance, attention and adaptive behavioral
responses (Aston-Jones & Bloom, 1981b; a; Aston-Jones et al., 1984; Aston-Jones et al.,
1994) . In fact, LC neurons exhibit the highest firing rates during waking and decreased
activity during slow-wave sleep, and are nearly quiescent during paradoxical sleep
(Aston-Jones & Bloom, 1981a). Moreover, LC neurons respond to autonomic influences
(Svensson, 1987) and are implicated in multiple autonomic functions (Morilak et al.,
1987a; b; Miyawaki et al., 1991). Afferents that innervate LC neurons can remarkably
influence the neural circuitry involved in the diversity of functions ascribed to the LC
(Aston-Jones et al., 1991).
Corticotropin-releasing factor (CRF), the hypothalamic neurohormone that
initiates the adrenocorticotropin release through its actions on corticotrophs of the
adenohypophysis (Vale et al., 1981; Cummings et al., 1983; Swanson et al., 1983), also
acts as a neurotransmitter in extrahypophyseal circuits that mediate behavioral and
autonomic responses to stressors. Anatomical studies have described CRFimmunoreactive fibers in noradrenergic LC neurons (Cummings et al., 1983; Swanson et
al., 1983). Specifically, CRF-axon terminals target noradrenergic dendrites in the LC
(Van Bockstaele et al., 1996d; Van Bockstaele et al., 1998b). In support of these data,

4

Reyes et al

POMC and CRF co-localization in the LC

physiological studies have shown that CRF administration intracerebroventricularly or by
microinfusion into the LC activated LC neurons (Valentino et al., 1983; Curtis et al.,
1997). In addition, CRF central administration or microinfusion into the LC increases NE
levels in prefrontal cortex, a region which derives NE solely from the LC (Lavicky &
Dunn, 1993; Smagin et al., 1995).
Anatomically, medullary afferents to the LC originate from the nucleus of the
solitary tract (NTS; (Van Bockstaele et al., 1998a; Van Bockstaele et al., 1999) that
provides monosynaptic input to noradrenergic dendrites in the LC (Van Bockstaele et al.,
1999) . Additionally, immunohistochemical and biochemical analyses have shown
POMC (Schwartzberg & Nakane, 1982) and CRF (Herbert & Saper, 1990) containing
cell bodies within the NTS. Taken together with the important role of these neuropeptides
in stress regulation (Baubet et al., 1994; Rubinstein et al., 1996; Vale et al., 1981;
Cummings et al., 1983; Swanson et al., 1983), it is important to elucidate the role of
POMC afferents that may express CRF as a co-transmitter in the regulation of
noradrenergic function.
Materials and Methods
Tissue preparation
Ten adult male Sprague-Dawley rats (Harlan Laboratories, Indianapolis, IN,
USA) weighing 225-250 g were used for this study. Five rats were used for examining
the cellular associations of POMC with tyrosine hydroxylase- (TH) or CRF-containing
cellular profiles in the dorsal pontine tegmentum using immunofluorescence while five
rats were used for examining cellular associations using electron microscopy. The rats
were housed 2-3 per cage on a 12-h light schedule in a temperature controlled (20 ºC)
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colony room. They were given standard rat chow and water. The procedures were
approved by the Institutional Animal Care and Use Committee of Thomas Jefferson
University and conformed to NIH guidelines. All efforts were made to utilize only the
minimum number of animals necessary to produce reliable scientific data and attempts
were made to minimize animal suffering.
Immunofluorescence microscopy
Rats were deeply anesthetized with sodium pentobarbital (60 mg/kg) and
transcardially perfused through the ascending aorta with 500 ml of 4% formaldehyde in
0.1 M phosphate buffer (PB; pH 7.4). Brains were then removed and post fixed in 4%
formaldehyde overnight at 4°C. Forty micrometer thick sections through the LC were cut
with a Vibratome (Technical Product International, St Louis, MO, USA) and rinsed
extensively in 0.1 M PB and 0.1 M tris-buffered saline (TBS; pH 7.6). Sections were
placed for 30 min in 1% sodium borohydride in 0.1 M PB to remove reactive aldehydes
and incubated in 0.5% bovine serum albumin (BSA) in 0.1M TBS for 30 min.
Subsequently, sections were then incubated in 0.5% bovine serum albumin (BSA) and
0.25% Triton X-100 in 0.1M TBS for 30 min and rinsed extensively in 0.1 M TBS.
Subsequently, sections were processed for POMC and TH or POMC and CRF
immunoreactivities.
Sections processed for POMC and TH were incubated in a cocktail containing
rabbit anti-POMC (Phoenix Pharmaceuticals Inc., Belmont, CA, USA) at 1:5,000 and
mouse anti-TH (Immunostar Inc., Hudson, WI, USA) at 1:1,000. Incubation time was 1518 h in a rotary shaker at room temperature. The antiserum to POMC (27-52 amino acid
sequence) was generated in rabbits against porcine POMC. The specificity of the mouse
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antiserum against TH was previously decribed (Van Bockstaele & Pickel, 1993) and it
specifically recognizes the catecholamine synthesizing enzyme.
Sections were then washed in 0.1 M TBS and incubated in a secondary antibody
cocktail containing flourescein isothiocyanate (FITC) goat-anti-rabbit (1:100; Jackson
ImmunoResearch Laboratories Inc., West Grove, PA, USA) and tetramethyl rhodamine
isothiocyanate (TRITC) donkey anti-mouse (1:100; Jackson ImmunoResearch) prepared
in 0.1 % BSA and 0.25% Triton X-100 in 0.1 M TBS for 2 h in the dark on a rotary
shaker.
Sections processed for POMC and CRF were incubated in a cocktail containing
rabbit anti-POMC at 1:5,000 and guinea pig anti-CRF (Peninsula Pharmaceuticals Inc.,
Belmont, CA, USA) at 1:1,000. Incubation time was 15-18 h in a rotary shaker at room
temperature. The antiserum to CRF was raised in guinea pig and recognizes human and
rat CRF. Sections were then washed in 0.1 M TBS and incubated in a secondary antibody
cocktail containing FITC goat-anti-rabbit (1:100; Jackson ImmunoResearch Laboratories
Inc.) and TRITC donkey anti-guinea pig (1:100; Jackson ImmunoResearch Laboratories
Inc.) prepared in 0.1 % BSA and 0.25% Triton X-100 in 0.1 M TBS for 2 h in the dark on
a rotary shaker.
Following incubation with the secondary antibodies, the tissues were washed
thoroughly in 0.1 M TBS. Afterwards, the tissues were mounted on slides and allowed to
dry in complete darkness. The slides were then dehydrated in a series of alcohols, soaked
in xylene and coverslipped using DPX (Sigma-Aldrich Inc., St. Louis, MO, USA). A
confocal microscope (Zeiss LSM 510 Meta, Carl Zeiss Inc., Thornwood, NY, USA) was
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used to visualize the immunofluorescence labeling and digital images were obtained and
imported using the LSM 5 image browser (Carl Zeiss Inc.).
Immunoelectron microscopy
The rats were deeply anesthetized with sodium pentobarbital (60 mg/kg) and
perfused transcardially through the ascending aorta with (1) 10 ml heparinized saline, (2)
50 ml of 3.75% acrolein (Electron Microscopy Sciences, Fort Washington, PA, USA),
and 200 ml of 2% formaldehyde in 0.1 M PB, ph 7.4. Immediately after perfusion
fixation, the brains were removed, sectioned into coronal slices and postfixed in the same
fixative overnight at 4ºC.
Alternate 40-µm thick sections through the rostrocaudal extent of the LC were
processed for electron microscopic analysis of POMC and TH or POMC and CRF in the
same section. Immunoperoxidase labeling was used to identify POMC immunoreactivity
in sections processed for POMC and TH while immunoperoxidase labeling was used to
identify CRF immunoreactivity for sections processed for POMC and CRF. Sections
containing the LC were placed for 30 min in 1% sodium brohydride in 0.1 M PB and
collected into 0.1 M PB to remove reactive aldehydes. Then sections were rinsed
extensively in 0.1 M PB and incubated in 0.5% BSA in 0.1 M TBS for 30 min followed
by several rinses in 0.1 M TBS. Tissue sections were incubated in primary antibody
cocktail of rabbit anti-POMC (1:5000) and mouse anti-TH (1:1,000) for 15-18 h at room
temperature. The following day, sections were rinsed three times in 0.1 M TBS
andincubated in biotinylated donkey anti-rabbit (1:400; Jackson ImmunoResearch
Laboratories, Inc.) for 30 min followed by rinses in 0.1 M TBS. Subsequently, a 30minute incubation of avidin-biotin complex (Vector Laboratories, Burlingame, CA, USA)
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followed. For all incubations and washes, sections were continuously agitated with a
rotary shaker. POMC was visualized by a 9-minute reaction in 22 mg of 3,3’diaminobenzidine (Sigma-Aldrich Inc.) and 10 Ol of 30% hydrogen peroxide in 100 ml of
0.1 M TBS. Some sections were collected, dehydrated and coverslipped for light
microscopic analysis of POMC immunoreactivity.
For gold-silver localization of TH (in sections processed for POMC and TH) and
POMC (in sections processed for POMC and CRF), sections were rinsed three times with
0.1 M TBS, followed by rinses with 0.1 M PB and 0.01 phosphate buffered saline (PBS;
pH 7.4). Sections were then incubated in a 0.2% gelatin-PBS and 0.8% BSA buffer for 10
min. This was followed by incubation in either goat anti-mouse IgG conjugate in 1 nm
gold particles (Amersham Bioscience Corp., Piscataway, NJ, USA) for TH or goat antirabbit IgG conjugate in 1 nm gold particles (Amersham Bioscience Corp.) at room
temperature for 2 h. Sections were then rinsed in buffer containing the same
concentration of gelatin and BSA as above and subsequently rinsed with 0.01 M PBS.
Sections were then incubated in 2% glutaraldehyde (Electron Microscopy Sciences) in
0.01 M PBS for 10 min followed by washes in 0.01 M PBS and 0.2 M sodium citrate
buffer (pH 7.4). A silver enhancement kit (Amersham Bioscience Corp.) was used for
silver intensification of the gold particles. The optimal times for silver enhancement time
were determined by empirical observation for each experiment and ranged 10-15 min.
Following intensification, tissues were rinsed in 0.2 M citrate buffer and 0.1 M PB, and
incubated in 2% osmium tetroxide (Electron Microscopy Sciences) in 0.1 M PB for 1 h,
washed in 0.1 M PB, dehydrated in an ascending series of ethanol followed by propylene
oxide and flat embedded in Epon 812 (Electron Microscopy Sciences; Leranth and
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Pickel, 1989). Thin sections of approximately 50-100 nm in thickness were cut with a
diamond knife (Diatome-US, Fort Washington, PA, USA) using a Leica Ultracut (Leica
Microsystems, Wetzlar, Germany). Sections were collected on copper mesh grids,
examined with an electron microscope (Morgagni, Fei Company, Hillsboro,OR, USA)
and digital images were captured using the AMT advantage HR/HR-B CCD camera
system (Advance Microscopy Techniques Corp., Danvers, MA, USA). Figures were
assembled and adjusted for brightness and contrast in Adobe Photoshop.
Control and data analysis
Tissue sections for electron microscopy were taken from rats with the best
immunocytochemical labeling and preservation of ultrastructural morphology. The
quantitative approach used in the present study is well established and has been described
previously (Van Bockstaele et al., 1996a; Van Bockstaele et al., 1996d; Van Bockstaele
et al., 1998a). Control sections were run in parallel in which one of the primary antisera
was omitted but the rest of the processing procedure was identical. Sections processed in
the absence of primary antibody did not exhibit immunoreactivity. The region of the LC
selected for electron microscopic analysis is shown in Figure 1A. For quantification of
labeled profiles in 40 µm-thick sections immunolabeled before embedding for electron
microscopy, we have observed that the collection of sections only from the surface of the
section minimizes artifacts that may be associated with incomplete penetration of
antisera. The analysis of tissue sections collected at the plastic-tissue interface ensured
that both markers were detectable in all sections used for analysis (Chan et al., 1990).
The cellular elements were identified based on the description of Peters and colleagues
(Peters & Palay, 1996; Peters et al., 1991). Somata contained a nucleus, Golgi apparatus
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and smooth endoplasmic reticulum. Proximal dendrites contained endoplasmic reticulum,
were postsynaptic to axon terminals and were larger than 0.7 µm in diameter. A terminal
was considered to form a synapse if it showed a junctional complex, a restricted zone of
parallel membranes with slight enlargement of the intercellular space, and/or associated
with postsynaptic thickening. Asymmetric synapses were identified by thick postsynaptic
densities (Gray’s type I; (Gray et al., 1959), in contrast, symmetric synapses had thin
densities (Gray’s type II; (Gray et al., 1959) both pre- and postsynaptically. A nonsynaptic contact or apposition was defined as an axon terminal plasma membrane
juxtaposed to that of a dendrite or soma devoid of recognizable membrane specializations
and no intervening glial processes.
In sections dually labeled for POMC and TH, the number of POMC axons and
axon terminals was grouped from randomly selected sections from ultrathin sections
taken from four nonadjacent sections from each animal (n = 5). At least four sections
were examined per animal. From the surface of the individual epon block containing the
tissue, at least four to eight ultrathin sections were collected. Fields of at least 11,000X
magnification showing POMC-labeled axons and axon terminals, and TH-labeled profiles
were captured and classified. This approach resulted in 405 POMC-labeled profiles. All
potential neuronal targets of POMC-labeled axon terminals throughout the analysis were
examined by defining their total associations with other profiles regardless of whether a
membrane specialization was seen within the plane of section. These associations
consisted of close appositions of neuronal plasma membranes not separated by glial
processes. These profiles were considered since opioids as well as other peptides are
released by exocytosis from nonsynaptic portions of plasmalemma (Thureson-Klein et
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al., 1986; Zhu et al., 1986; Karhunen et al., 2001). Postsynaptic targets considered
included dendrites containing gold-silver labeling for TH, dendrites lacking gold-silver
labeling for TH, unlabeled terminals and glial processes. POMC-labeled profiles forming
clear synaptic specializations were classified as symmetric (Gray’s Type II) or
asymmetric (Gray’s Type I). On the other hand, undefined contacts were characterized by
a junctional complex that was not readily identifiable.
In sections dually labeled for POMC and CRF, POMC axons and axon terminals
were studied from fields of at least 11,000X magnification found in at least four ultrathin
sections taken from four sections from each animal (n = 5). Fields showing POMClabeled axons and axon terminals and CRF-labeled neuropil were captured and classified.
This approach resulted in 657 POMC-labeled profiles.
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Results
By light microscopy, the LC was visualized using an antibody directed against
POMC and appeared as dense immunoreactive processes distributed in the ventromedial
aspect of the LC in the rostral pons (Fig. 1A). Fewer POMC-labeled fibers were found
dorsolaterally. Immunofluorescence labeling for POMC and TH was visualized in
coronal sections of the LC (Figs 1C-D). Immunocytochemical labeling for TH at rostral
pontine levels showed considerable TH-immunoreactive dendrites extending from somata
in the LC, medial and ventral to the fourth ventricle (Fig. 1B-D) consistent with previous
studies (Van Bockstaele et al., 1995; Shipley et al., 1996). At caudal levels, THimmunoreactive dendrites of the peri-LC area, immediately medial to the core of LC
neurons, was evidently less dense than that of the rostral levels (not shown). Conversely,
the core of the LC exhibited a dense population of TH-immunoreactive somata (Fig. 1B
and D). Immunocytochemical labeling for POMC revealed varicose processes within the
peri-LC at rostral levels (Figs 1B-D). Numerous POMC-immunoreactive processes
extended into the core of the LC where the somata of LC neurons are found (Figs 1B and
D). POMC-immunoreactive fibers were morphologically heterogeneous. Some fibers
were thin and beaded while others were thicker and lacked varicosities (Figs 1B-D).
Ultrastructural analysis of POMC and TH
At the electron microscopic level, immunoperoxidase labeling for POMC and
immunogold-silver labeling for TH were localized within single sections of the LC.
POMC immunoreactivity was identified primarily in unmyelinated axon terminals (Fig.
2). POMC-labeled dense core vesicles could be identified adjacent to the plasmalemma
most commonly apposed to astrocytic process (Fig. 2A). Morever, POMC-labeled axon
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terminals contained abundant small clear spherical vesicles (Figs 2A-C). Often,
peroxidase labeling for POMC rimmed the membranes of small clear spherical vesicles
(Figs 2A-B). Large dense core vesicles were observed in POMC-labeled terminals (Figs
2 & D) and contained abundant peroxidase labeling. TH-immunoreactivity was primarily
localized to somatodendritic processes (Figs 2C-D), although occasionally axon terminals
exhibited gold-silver labeling for TH.
POMC-labeled axon terminals showed synaptic specializations with TH-labeled
and -unlabeled dendrites (Figs 2B-C). Semiquantitative analysis revealed that POMClabeled axon terminals frequently contacted TH-labeled dendrites (29%; n = 118). When
synaptic specializations were identifiable, they were either of the symmetric, inhibitory
type (Gray’s type; Gray, 1959) or the asymmetric, excitatory type. Some of the POMClabeled axon terminals did not form clearly defined synaptic specializations with
postsynaptic targets in the single planes of section analyzed (Fig. 2C). Of the 118 POMClabeled axon terminals that were in direct contact with TH-labeled dendrites, 39%
(46/118) were of the symmetric type while 18% (21/118) were asymmetric. The
remainder did not form well defined synapses in the plane of sections analyzed.
Approximately, 15% of the POMC-labeled axon terminals were occasionally apposed to
other axon terminals. Frequently, appositions with other terminals lacked the specialized
densities characteristic of axo-axonic synapses.
Cellular interactions between POMC and CRF
Immunofluorescence labeling for POMC and CRF was visualized in coronal
sections in the rostral pontine tegmentum (Figs 3A-C). Immunocytochemical labeling for
POMC and CRF exhibited a punctate pattern of staining and densely labeled fibers (Figs
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3A-C). POMC immunoreactivity was localized to CRF-labeled processes and this was
more prominent in the peri-LC as compared to the core region (Fig. 3C).
Ultrastructural analysis of POMC and CRF
At the ultrastructural level, POMC immunolabeling showed a similar distribution
as described above (Figs 4 and 5). CRF immunoreactivity was restricted to axons and
axon terminals and was rarely seen in somata and dendrites consistent with previous
findings (Van Bockstaele et al., 1996d; Van Bockstaele et al., 1998b). Of 657 POMClabeled axon terminals, where CRF immunoreactivity was present in the neuropil, 27%
(178/657) contained CRF immunoreactivity. Conversely, of 542 CRF-labeled terminals
where POMC immunoreactivity was present in the neuropil, 33% (178/542) were dually
labeled. The dually-labeled terminals contained several recognizable small clear vesicles
and one or more mitochondria (Figs 4A-D). Some of these also contained large dense
core vesicles (Figs 4A-C). The dually-labeled axon terminals contacted primarily
medium to small sized dendrites. Some of these terminals did not form recognizable
synaptic specializations in the single planes of section analyzed. However, when synaptic
specializations were recognizable, they were more frequently of the asymmetric type
(Figs 4A, 4C and 5A-B). Of 178 POMC-labeled axon terminals that contained CRF
immunoreactivity, 29% and 21% formed asymmetric and symmetric synapses (Figs 4D
and 5C), respectively. The remainder did not form identifiable synapses in sections
examined.
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Discussion
The present findings demonstrate the first ultrastructural evidence that POMCimmunoreactive axon terminals form synaptic specializations with TH-containing
dendrites in the LC. In addition, results show that POMC and CRF co-exist in single axon
terminals in the LC. These data provide a neuroanatomical substrate whereby CRF
afferents containing POMC derived peptides, such as -endorphin, are positioned to
impact the LC-NE system. This substrate could underlie activation of the brain NE
system by stress and may serve to integrate autonomic components of the stress response
associated with functions of LC neurons.
The present results provide the first ultrastructural description of POMC-labeled
fibers in the rat LC. POMC fibers have been demonstrated in the LC in aquatic toad
(Tuinhof et al., 1998). Our findings of the POMC distribution in the LC are consistent
with that of -endorphin, a peptide synthesized from POMC described in earlier studies,
(Bloom et al., 1978a) where fibers course toward the middle third of the LC in the
ventromedial aspect but are scant at caudal levels. By using dual immunoelectron
microscopy, we provide the first ultrastructural evidence that POMC fibers form synaptic
specializations with catecholamine-containing dendrites in the LC. In addition, we
demonstrate that POMC-labeled fibers form primarily symmetric synapses that are
correlated with inhibitory transmission, with TH-labeled dendrites in the LC (Peters &
Palay, 1996; Peters et al., 1991).
-endorphin influences nociception (Foley et al., 1979; Yaksh et al., 1982;
Bertolini et al., 1986; Baubet et al., 1994), cardiovascular (Laubie et al., 1977; Holaday,
1983), respiratory (Moss & Friedman, 1978) and stress responses (Baubet et al., 1994).
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As such, intracoerulear injections of -endorphin suppressed long lasting posture
asymmetry and movement (Bertolini et al., 1986) and significantly elevated nociceptive
threshold (Yaksh et al., 1982) which were reversed by naloxone, an opioid antagonist. In
addition, -endorphin administration via the cisterna magna caused a transient increase in
blood pressure and heart rate followed by a delayed hypotension and bradycardia (Laubie
et al., 1977). Loh and colleagues (Loh et al., 1976) demonstrated that -endorphin
inhibits striatal dopamine release in vitro. Furthermore, in situ hybridization study
showed that acute stress increased POMC mRNA expression in the mediobasal
hypothalamus (Baubet et al., 1994). Our present findings indicate that POMC modulates
LC neurons directly in the dorsal pontine tegmentum. Hence, the central effects of endorphin described earlier may represent actions of this potent peptide on LC neurons as
these neurons are engaged in similar activities.
Previous studies have shown that the arcuate nucleus (ARC) and NTS are
enriched with POMC-immunoreactive perikarya (Schwartzberg & Nakane, 1982; Gee et
al., 1983). ARC and NTS are brain regions involved in a myriad of autonomic functions
such as cardiovascular (Lu et al., 2002; Weston et al., 2003; Balan Junior et al., 2004;
Guo & Moazzami, 2004), nociception (Sun & Yu, 2005; Tonosaki et al., 2005) and stress
responses (Buller, 2003; Dayas et al., 2004; Helmreich et al., 2005; Kas et al., 2005;
Sergeyev et al., 2005). Similarly, LC neurons have been implicated in autonomic
functions including cardiovascular, respiratory and stress responses (Aston-Jones et al.,
1991; Allen & Cechetto, 1992; Cechetto & Chen, 1992; Reis & Golanov, 1997;
Valentino et al., 1998; Machado, 2001). POMC fibers in the LC may be derived from the
ARC and NTS since anatomical studies using retrograde tracing revealed that neurons
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from the ARC send projections to the LC (Luppi et al., 1995). In addition, we have
previously demonstrated that efferent projections from the NTS monosynaptically
innervate dendrites exhibiting TH-immunoreactivity in the rostral LC area where we
found abundant POMC fibers (Van Bockstaele et al., 1999). The present study
demonstrating dual-labeling for POMC-immunoreactive terminals and THimmunoreactive dendrites show that majority of the synapses identified were of
symmetric type. These suggest that the ARC and NTS may be possible sources of POMC
afferent fibers projecting to the LC that could regulate LC activity.
In the present study, immunofluorescence showed prominent co-localization of
POMC and CRF terminals in the ventromedial aspect of the LC. However, there was
little evidence of POMC and CRF co-localization in the dorsolateral aspect of the LC.
The anatomical distribution of POMC and CRF co-localization is in contrast to the
distribution of fibers dually labeled for enkephalin and CRF in the LC (Tjoumakaris et
al., 2003) which was visualized more in the LC core and some observed dorsolaterally.
This was confirmed at the ultrastructural level, where POMC and CRF dually labeled
terminals were located primarily in the ventromedial aspect of the LC. With regard to the
degree of co-localization with enkephalin (12% of enkephalin terminals; Tjoumakaris et
al., 2003), the percentage of POMC-labeled terminals that exhibited CRF
immunoreactivity in this study was greater. Therefore, although many POMC and CRF
terminals were singly labeled, this study also shows a distinct population of terminals that
co-localized both peptides.
The NTS is a potential source of POMC and CRF dually labeled terminals in the
LC because it contains numerous CRF (Herbert & Saper, 1990) and POMC
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(Schwartzberg & Nakane, 1982) neurons. Taken with our previous demonstration that
NTS efferents form synaptic specializations with catecholaminergic LC dendrites (Van
Bockstaele et al., 1999), it is tempting to speculate that CRF neurons in the NTS that coexpress -endorphin innervate LC neurons. Future studies would be useful to elucidate
whether these terminals arise from the NTS.
Our findings also show that POMC/CRF afferents containing axon terminals form
asymmetric (29%) and symmetric (21%) synapses with postsynaptic targets. Asymmetric
synapses have been correlated with excitatory transmission whereas symmetric synapses
have been correlated with inhibitory transmission (Gray 1959; Carlin et al., 1980; Carlin
et al., 1981; Peters et al., 1991; Peters et al., 1996). These data suggest that POMC/CRF
afferents may originate from different afferent nuclei (ARC vs NTS) based on their
morphological heterogeneity. In addition, the heterogeneous morphological
differentiation of the synapses may indicate co-existence with either excitatory or
inhibitory amino acid transmitter such as glutamate or gamma-aminobutyric acid
(GABA). We have shown that CRF forms primarily asymmetric synapses with LC
dendrites and that some of these contain glutamate (30%; Valentino et al., 2001).
However, we also showed that some CRF terminals contain GABA (5%) suggesting that,
in the present study POMC/CRF terminals may co-express distinct amino acid
transmitters, and by the virtue of this, exhibit distinct synaptic specializations. Future
studies are required to determine whether POMC/CRF terminals co-express different
amino acid transmitters.
In conclusion, our present results suggest that POMC is localized to efferents that
target LC neurons, a circuit that may facilitate modulation of autonomic functions

19

Reyes et al

POMC and CRF co-localization in the LC

including nociceptive, cardiovascular and respiratory functions. In addition, afferents
expressing both CRF and POMC as co-transmitters may be involved in regulation of
stress responses known to be subserved by this region.

Abbreviations
CRF, corticotropin-releasing factor; LC, locus coeruleus; POMC, proopiomelanocortin;
TH, tyrosine hydroxylase;
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Figure Legends
Figure 1. A. Brightfield photomicrographs of proopiomelanocortin (POMC) in the locus
coeruleus (LC). Arrows indicate individual POMC-labeled processes. Note that many are
highly beaded and thin. Inset in panel A shows a schematic diagram adapted from the rat
brain atlas of Swanson (1992) depicting the region sampled. In the inset, arrows indicate
dorsal (D) and medial (M) orientation of the sections illustrated. B-D. Confocal
fluorescence photomicrographs of POMC (arrowheads) labeled with fluorescein
isothiocyanate (green) and tyrosine hydroxylase (TH; arrows) labeled with rhodamine
isothiocyanate (red) in the LC. Abundant POMC-labeled processes are associated with
TH-labeled dendrites (C). This association extends into the LC somatic region (B and D).
Scale bars, 100 µm. Abbreviations: scp, superior cerebellar peduncle; D, dorsal; IV,
fourth ventricle; M, medial; mlf, medial longitudinal fasciculus; moV, motor root of the
trigeminal nucleus; V, motor nucleus of the trigeminal nucleus.
Figure 2. Electron photomicrographs showing peroxidase labeling for
proopiomelanocortin (POMC) and gold-silver labeling for tyrosine hydroxylase (TH) in
the locus coeruleus (LC). A. Peroxidase labeling can be seen in a POMC-labeled terminal
(POMC-t) that contains dense core vesicles (dcv). Several unlabeled terminals (ut) that
contain unlabeled dense core vesicles (udcv) can be seen in the neuropil. B. A
peroxidase-labeled POMC-t forms a symmetric synapse (arrow) with an unlabeled
dendrite (ud). C. A peroxidase-labeled POMC-t that contains dcv is directly contacted
(double arrow) with a TH-labeled dendrite (TH). Arrowheads indicate gold-silver
labeling for TH. Arrows point to symmetric synapses formed by unlabeled terminals (ut).
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D. Another peroxidase-labeled POMC-t forms a symmetric synapse (arrow) with a TH-d.
Scale bars, 0.50 µm. ma, myelinated axon.
Figure 3. Confocal fluorescence photomicrographs showing co-localization of
proopiomelanocortin (POMC) and corticotropin-releasing factor (CRF) in the locus
coeruleus (LC). A and A1. CRF-labeling was detected by rhodamine isothiocyanate
(red). Arrows point to individual CRF-labeled varicose processes that contain POMC.
Arrowheads point to varicose processes that contain CRF. B and B1. POMC-labeling
was detected by fluorescein isothiocyanate (green). Arrows point to individual POMClabeled varicose processes that contain CRF. Arrowheads point to varicose processes
that contain POMC. C and C1. Merged image. Arrows point to POMC- and CRF-dual
labeled varicose processes. Arrowheads point to either POMC or CRF varicose
processes. Scale bars, 100 µm.
Figure 4. Electron photomicrographs showing convergence and co-existence of
proopiomelanocortin (POMC) and corticotropin-releasing factor (CRF) in the locus
coeruleus (LC). A. A gold-silver labeled (arrowheads) POMC terminal (POMC-t) and
peroxidase-labeled CRF axon terminal (CRF-t) synapse (curved arrows) with a common
dendrite (d). Another peroxidase-labeled CRF-t can also be identified in the neuropil. B.
Two axon terminals containing both peroxidase labeling for CRF and gold-silver labeling
(arrowheads) for POMC contact (arrow) a dendrite (d). C-D. Axon terminals containing
both peroxidase labeling for CRF and gold-silver labeling (arrowheads) for POMC
(POMC + CRF-t) contact dendrites (d) in the LC. Scale bars, 0.5µm.
Figure 5. Electron photomicrographs showing synaptic specializations formed by
proopiomelanocortin (POMC) and corticotropin-releasing factor (CRF) axon terminals in
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the locus coeruleus (LC). A-B. Gold-silver labeling for POMC (arrowheads) and
peroxidase-labeling for CRF (POMC+ CRF-t) can be found in axon terminal forming
asymmetric synapses (arrows) with dendrites (d). C. A POMC+ CRF-t forms a
symmetric synapse (curved arrow) with a dendrite (d). Scale bars, 0.5µm.
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